Despite Barriers, Financial Institutions are Clear About AI's Greatest Impact
HTEC, a global AI-first provider of software and hardware design and engineering services, today released The State of AI in Financial Services & Insurance 2025, a first industry subset of its global research report in AI. This publication offers one of the clearest views to date into how financial institutions are adopting and scaling artificial intelligence. This industry-focused report analyzes insights from 250 C-suite leaders within financial services and insurance, drawn from HTEC’s broader global study of 1,529 C-suite executives—including CIOs, CTOs, CDOs, CPOs, CFOs, COOs, CEOs and CSOs—across Saudi Arabia, the UAE, the United Kingdom, the United States, Germany and Spain.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215790717/en/
Executive Summary: The State of AI in Financial Services and Insurance 2025
The findings confirm a decisive shift in the industry: not a single respondent said AI is not a priority. Leaders overwhelmingly agree on AI’s potential, but scaling AI across the enterprise remains a challenge, with only 41.6% of leaders reporting AI is fully embedded across multiple functions, and a similar share (42.8%) noting deployment in limited areas. For HTEC, this mirrors the realities observed in long-term client engagements. Financial institutions understand the stakes, and the opportunity is clear, however, the friction begins when they attempt to connect isolated use cases and integrate AI into the core systems and workflows of the organization. Executives describe challenges that go far beyond technology itself.
Challenges: Integration, Talent, and Alignment
Despite near-universal adoption, FSI organizations face significant hurdles:
- Integration Complexity: 40% of executives cite difficulty embedding AI into existing processes and legacy systems as the top barrier to scale.
- Leadership Alignment: 36% report a lack of strategic alignment across leadership, slowing enterprise-wide transformation.
- Talent Shortages: Data engineering and analytics (38%), cybersecurity and data privacy (33%), DevOps/automation/edge skills (32%), and AI/ML expertise (31%) are the most acute capability gaps. These shortages drive higher costs (41%), reduce innovation (38%), and slow time to market (34%).
- AI Literacy: Only 38% of executive teams are rated as having high AI literacy.
Opportunities: Where AI Delivers Value
FSI leaders are clear about AI’s most valuable applications:
- Automating Underwriting: 42% see faster, more accurate risk assessment as a primary benefit.
- Fraud Detection and Risk Management: 39% highlight real-time pattern recognition and anomaly detection.
- Personalization and Customer Engagement: 38% focus on predictive, context-aware digital interactions.
- AI-powered Research and Advisory: 38% value real-time, context-rich insights for decision-making.
- Claims Automation: 34% note faster, more reliable outcomes for customers.
The report also finds that readiness to capture AI’s value remains uneven. While 23% of organizations feel equipped to adopt and scale AI rapidly, a much larger share—52%—say they are either still learning and experimenting with limited ability to capture value or struggling to keep pace with the speed of change. This unevenness, combined with leadership alignment gaps and technical constraints, underscores the need for clearer roadmaps, stronger engineering foundations combined with partnerships where internal capacities are weak, and more deliberate workforce enablement.
“Firms that move fastest are often those where technology and business leadership work as one team, united around measurable outcomes rather than experimenting for its own sake. Partnering across functions and with external experts is essential to accelerate value creation and realize the full potential of AI in financial services,” said Jamie Alsop, Managing Partner for Financial Services & Insurance at HTEC and a co-author of the report.
The State of AI in Financial Services & Insurance 2025 is now available for download.
About HTEC
HTEC Group Inc. is a global AI-first provider of strategic, software and hardware embedded design and engineering services, specializing in Advanced Technologies, Financial Services, MedTech, Automotive, Telco, and Enterprise Software & Platforms. HTEC has a proven track record of helping Fortune 500 and hyper-growth companies solve complex engineering challenges, drive efficiency, reduce risks, and accelerate time to market. HTEC prides itself on attracting top talent and has strategically chosen the locations of its 20+ excellence centers to enable this.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251215790717/en/
Contacts
Media Contact:
media@htecgroup.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Volante Technologies Customers Successfully Navigate Critical Regulatory Deadlines for EU SEPA Instant and Global SWIFT Cross-Border Payments16.12.2025 10:00:00 CET | Press Release
Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format. SEPA IPR is a significant European milestone, requiring payments to be made within 10 seconds and at any time of day, throughout the year. Adoption was mandatory and Eurozone banks were compelled to meet strict deadlines, with January 9th, 2025 the deadline for receiving incoming instant payments and October 9th the deadline for sending outgoing instant payments. The latest deadline impacted more than 700 banks across Europe, with non-compliance penalties reaching at least 10% of annual net turnover. SWIFT SRG 2025 is another seismic update, representing the
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press Release
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge ® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press Release
Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support commercial manufacturing of Omisirge® for this additional indication at its state-of-the-art cGMP cell therapy manufacturing facility in Hopkinton, MA. “We are excited to expand our collaboration with RoslinCT to add US manufacturing as Omisirge® moves into its next phase with the recent FDA approval for patients suffering from severe apl
Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 07:00:00 CET | Press Release
Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It proves a supplier has undergone an exhaustive audit of its governance, security controls, and operational processes. For Dutch financial institutions, this qualificatio
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press Release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom